News Release

SCAI leaders available for comment on studies released at European Society for Cardiology Congress

Peer-Reviewed Publication

Weber Shandwick Worldwide

What: New studies and clinical trials and data to be released on interventional cardiology, percutaneous intervention (PCI), including use of angioplasty, renal artery stenting, bare metal stents and drug eluting stents

Who:
Bonnie Weiner, M.D., M.S.E.C., M.B.A., FSCAI
President, SCAI
Interim Chair of Cardiovascular Medicine and Professor of Medicine,
St Vincent Hospital at Worcester Medical Center
Boston, MA.

She has authored or co-authored over 75 papers including longitudinal studies involving the investigation and treatment of atherosclerosis, thrombolysis, and restenosis as well as basic cardiovascular research.

Steven R. Bailey, M.D., FSCAI
Secretary, SCAI
Interim Chief of Division of Cardiology
Professor of Medicine and Radiology
Janey Briscoe Distinguished Chair
University of Texas Health Sciences Center at San Antonio

Dr. Bailey is certified by the American Board of Internal Medicine and the National Board of Medical Examiners, and he holds subspecialty board certification in Cardiovascular disease and Interventional cardiology.

Why: Numerous studies, trials and data reporting are released at the European Society for Cardiology Congress 2007 (ESC 2007), which begins September 1 and concludes September 5, 2007, in Vienna, Austria. ESC 2007 is a medical conference that attracts cardiology experts and leaders from around the world.

When: As requested from September 2–5, 2007

When: New studies, data and trial results will be released beginning September 2, 2007, at 8:01 am Vienna time.

Specific studies of interest:

  • "Conventional Stent in ST-Segment Elevation Myocardial Infarction" (PASSION) study presented by Dr. Maurits T. Dirksen, M.D.
  • "Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention" (ASSENT-4 PCI) presented by Professor Hans-Richard Arntz
  • "REGINA study: Management of oral antiplatelet therapy depends on the Dr." presented by Jean-Phillipe Collet
  • "PACTO Study: Long-term safety and efficacy of paclitaxel-eluting Stents in chronic total coronary occlusions: 3 year follow-up from the PACTO study," presented by Professor Gerald S. Werner, M.D., FESC
  • "Insights from the French left main taxus registry: Promising results of percutaneous coronary intervention for the treatment of unprotected left main disease using DES" presented by Professor Thierry Lefevre, M.D.
  • "Renal Artery Stenosis: A disease that should not be underestimated but intensively treated," presented by Dr. Romain Ollivier
  • Biodegradable polymer absorbable stents may shorten obligatory period of double antiplatelet therapy and enhance overall clinical and economic benefits," presented by Pawel Buszman
  • "The study in which elderly patients are treated with percutaneous coronary intervention (PCI) using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) presented by Jorg Carlsson
  • "Insights from the French left main Taxus registry: Promising results of percutaneous coronary intervention for the treatment of unprotected left main disease using DES," presented by Professor Thierry Lefevre, M.D.
  • "The DANAMI-2 study," presented by Michael Maeng, M.D., Ph.D.
  • "Charisma sub-study on discontinuation of clopidogrel," presented by Professor Jean-Phillippe Collet
  • "Study on mortality in women after coronary angioplasty for heart attack," presented by Monica Masotti, M.D.
  • "Which patients benefit more drug-eluting stents: A meta-regression analysis of 31 randomized trials comparing drug eluting stents to bare metal stents," presented by Dr. Raul Moreno
###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.